Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients.

Luca DiamantiPaola BorrelliRaffaele DubbiosoMargherita CapassoClaudia MorelliChristian LunettaAntonio PetrucciGabriele MoraPaolo VolantiMaurizio InghilleriLucio TremolizzoJessica MandrioliLetizia MazziniMarcella VedovelloGabriele SicilianoMassimiliano FilostoSabrina MatàCristina Montomolinull null

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)

DYALS scale is reliable, manageable, and easily usable for the screening of dysphagia in ALS. It can be shared with all the Italian ALS centres in order to collect uniform data for therapeutic strategies and clinical trials.

Keyphrases

clinical trial
amyotrophic lateral sclerosis
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
randomized controlled trial
electronic health record
machine learning
big data
cross sectional
patient reported
patient reported outcomes
open label
psychometric properties